A new possible term in the world of Biotech, Biogenerics? We currently have Pharmacogenomics working and now perhaps an interest with the Generic Drug business investing in Biotech as well or perhaps the availability of a generic without a long patent protection period? I am not quite sure...
Teva also stated it plans to sue Novartis and Momenta for patent infringement. Recently in the news was the announcement to buy Bentley Pharmaceuticals. “Teva USA products are marketed to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies....